Document is current

Any future updates will be listed below

Serum uric acid as a surrogate marker of favorable response to bevacizumab treatment in patients with metastatic colon cancer

Crossref DOI link: https://doi.org/10.1007/s12094-016-1485-1

Published Online: 2016-01-19

Published Print: 2016-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark